The 7 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 32.00, with a high estimate of 44.00 and a low estimate of 20.00. The median estimate represents a +62.03% increase from the last price of 19.75.
The current consensus among 8 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.63
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.